nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—UGT2B7—Epirubicin—uterine cancer	0.0878	0.135	CbGbCtD
Ezetimibe—ABCC3—Etoposide—uterine cancer	0.0791	0.121	CbGbCtD
Ezetimibe—UGT1A1—Etoposide—uterine cancer	0.0591	0.0906	CbGbCtD
Ezetimibe—ABCG2—Dactinomycin—uterine cancer	0.0576	0.0884	CbGbCtD
Ezetimibe—ABCC3—Doxorubicin—uterine cancer	0.054	0.0828	CbGbCtD
Ezetimibe—ABCC2—Carboplatin—uterine cancer	0.0428	0.0657	CbGbCtD
Ezetimibe—ABCG2—Carboplatin—uterine cancer	0.0387	0.0594	CbGbCtD
Ezetimibe—ABCC2—Etoposide—uterine cancer	0.036	0.0551	CbGbCtD
Ezetimibe—ABCG2—Etoposide—uterine cancer	0.0325	0.0499	CbGbCtD
Ezetimibe—ABCB1—Progesterone—uterine cancer	0.0262	0.0402	CbGbCtD
Ezetimibe—ABCC2—Doxorubicin—uterine cancer	0.0245	0.0376	CbGbCtD
Ezetimibe—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0237	0.0363	CbGbCtD
Ezetimibe—ABCG2—Doxorubicin—uterine cancer	0.0222	0.034	CbGbCtD
Ezetimibe—ABCB1—Dactinomycin—uterine cancer	0.0208	0.0319	CbGbCtD
Ezetimibe—CYP3A4—Progesterone—uterine cancer	0.0157	0.0241	CbGbCtD
Ezetimibe—ABCB1—Etoposide—uterine cancer	0.0117	0.018	CbGbCtD
Ezetimibe—ABCB1—Doxorubicin—uterine cancer	0.00799	0.0123	CbGbCtD
Ezetimibe—CYP3A4—Etoposide—uterine cancer	0.00702	0.0108	CbGbCtD
Ezetimibe—SOAT1—exocrine gland—uterine cancer	0.00585	0.0712	CbGeAlD
Ezetimibe—CYP3A4—Doxorubicin—uterine cancer	0.00479	0.00735	CbGbCtD
Ezetimibe—SOAT1—myometrium—uterine cancer	0.00324	0.0395	CbGeAlD
Ezetimibe—ANPEP—myometrium—uterine cancer	0.0031	0.0378	CbGeAlD
Ezetimibe—SOAT1—uterine cervix—uterine cancer	0.00252	0.0307	CbGeAlD
Ezetimibe—SOAT1—smooth muscle tissue—uterine cancer	0.00245	0.0299	CbGeAlD
Ezetimibe—ANPEP—epithelium—uterine cancer	0.00243	0.0296	CbGeAlD
Ezetimibe—ANPEP—uterine cervix—uterine cancer	0.00241	0.0294	CbGeAlD
Ezetimibe—SOAT1—decidua—uterine cancer	0.0024	0.0293	CbGeAlD
Ezetimibe—SOAT1—renal system—uterine cancer	0.00236	0.0287	CbGeAlD
Ezetimibe—ANPEP—smooth muscle tissue—uterine cancer	0.00234	0.0286	CbGeAlD
Ezetimibe—ANPEP—decidua—uterine cancer	0.0023	0.028	CbGeAlD
Ezetimibe—SOAT1—endometrium—uterine cancer	0.00228	0.0278	CbGeAlD
Ezetimibe—ANPEP—renal system—uterine cancer	0.00226	0.0275	CbGeAlD
Ezetimibe—SOAT1—mammalian vulva—uterine cancer	0.00221	0.0269	CbGeAlD
Ezetimibe—UGT2B15—female reproductive system—uterine cancer	0.0022	0.0268	CbGeAlD
Ezetimibe—ANPEP—endometrium—uterine cancer	0.00218	0.0266	CbGeAlD
Ezetimibe—ANPEP—mammalian vulva—uterine cancer	0.00211	0.0257	CbGeAlD
Ezetimibe—ANPEP—uterus—uterine cancer	0.00201	0.0245	CbGeAlD
Ezetimibe—SOAT1—female reproductive system—uterine cancer	0.00189	0.023	CbGeAlD
Ezetimibe—ANPEP—female reproductive system—uterine cancer	0.00181	0.022	CbGeAlD
Ezetimibe—SOAT1—female gonad—uterine cancer	0.00172	0.0209	CbGeAlD
Ezetimibe—SOAT1—vagina—uterine cancer	0.00171	0.0208	CbGeAlD
Ezetimibe—UGT2B7—renal system—uterine cancer	0.00168	0.0204	CbGeAlD
Ezetimibe—ANPEP—female gonad—uterine cancer	0.00164	0.02	CbGeAlD
Ezetimibe—ANPEP—vagina—uterine cancer	0.00163	0.0199	CbGeAlD
Ezetimibe—UGT1A1—renal system—uterine cancer	0.00143	0.0174	CbGeAlD
Ezetimibe—UGT2B7—female reproductive system—uterine cancer	0.00134	0.0163	CbGeAlD
Ezetimibe—SLCO1B1—renal system—uterine cancer	0.00119	0.0144	CbGeAlD
Ezetimibe—ABCC3—decidua—uterine cancer	0.00115	0.014	CbGeAlD
Ezetimibe—ABCC3—renal system—uterine cancer	0.00113	0.0137	CbGeAlD
Ezetimibe—SOAT1—lymph node—uterine cancer	0.00111	0.0135	CbGeAlD
Ezetimibe—ANPEP—lymph node—uterine cancer	0.00106	0.0129	CbGeAlD
Ezetimibe—SLCO1B1—female reproductive system—uterine cancer	0.00095	0.0116	CbGeAlD
Ezetimibe—ABCC3—female reproductive system—uterine cancer	0.000901	0.011	CbGeAlD
Ezetimibe—ABCG2—myometrium—uterine cancer	0.0009	0.011	CbGeAlD
Ezetimibe—ABCC2—renal system—uterine cancer	0.000899	0.0109	CbGeAlD
Ezetimibe—ABCC3—female gonad—uterine cancer	0.00082	0.00998	CbGeAlD
Ezetimibe—ABCC2—female reproductive system—uterine cancer	0.00072	0.00877	CbGeAlD
Ezetimibe—ABCG2—uterine cervix—uterine cancer	0.000701	0.00853	CbGeAlD
Ezetimibe—ABCG2—decidua—uterine cancer	0.000668	0.00813	CbGeAlD
Ezetimibe—ABCG2—endometrium—uterine cancer	0.000634	0.00772	CbGeAlD
Ezetimibe—ABCG2—mammalian vulva—uterine cancer	0.000613	0.00746	CbGeAlD
Ezetimibe—ABCG2—uterus—uterine cancer	0.000584	0.00711	CbGeAlD
Ezetimibe—ABCC3—lymph node—uterine cancer	0.000527	0.00642	CbGeAlD
Ezetimibe—ABCG2—female gonad—uterine cancer	0.000478	0.00582	CbGeAlD
Ezetimibe—ABCG2—vagina—uterine cancer	0.000475	0.00578	CbGeAlD
Ezetimibe—CYP3A4—renal system—uterine cancer	0.000457	0.00556	CbGeAlD
Ezetimibe—ABCB1—myometrium—uterine cancer	0.000444	0.00541	CbGeAlD
Ezetimibe—ABCC2—lymph node—uterine cancer	0.000421	0.00513	CbGeAlD
Ezetimibe—CYP3A4—female reproductive system—uterine cancer	0.000366	0.00445	CbGeAlD
Ezetimibe—ABCB1—epithelium—uterine cancer	0.000349	0.00424	CbGeAlD
Ezetimibe—ABCB1—uterine cervix—uterine cancer	0.000346	0.00421	CbGeAlD
Ezetimibe—ABCB1—decidua—uterine cancer	0.000329	0.00401	CbGeAlD
Ezetimibe—ABCB1—renal system—uterine cancer	0.000323	0.00394	CbGeAlD
Ezetimibe—Myalgia—Dactinomycin—uterine cancer	0.000318	0.00175	CcSEcCtD
Ezetimibe—Hypersensitivity—Progesterone—uterine cancer	0.000318	0.00175	CcSEcCtD
Ezetimibe—Discomfort—Dactinomycin—uterine cancer	0.000314	0.00173	CcSEcCtD
Ezetimibe—ABCB1—endometrium—uterine cancer	0.000313	0.00381	CbGeAlD
Ezetimibe—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00031	0.00171	CcSEcCtD
Ezetimibe—Asthenia—Progesterone—uterine cancer	0.000309	0.0017	CcSEcCtD
Ezetimibe—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000309	0.0017	CcSEcCtD
Ezetimibe—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000309	0.0017	CcSEcCtD
Ezetimibe—ABCG2—lymph node—uterine cancer	0.000307	0.00374	CbGeAlD
Ezetimibe—Pruritus—Progesterone—uterine cancer	0.000305	0.00168	CcSEcCtD
Ezetimibe—Infection—Dactinomycin—uterine cancer	0.000303	0.00166	CcSEcCtD
Ezetimibe—ABCB1—mammalian vulva—uterine cancer	0.000302	0.00368	CbGeAlD
Ezetimibe—Thrombocytopenia—Dactinomycin—uterine cancer	0.000298	0.00164	CcSEcCtD
Ezetimibe—Diarrhoea—Progesterone—uterine cancer	0.000295	0.00162	CcSEcCtD
Ezetimibe—Erythema multiforme—Etoposide—uterine cancer	0.000294	0.00161	CcSEcCtD
Ezetimibe—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000289	0.00159	CcSEcCtD
Ezetimibe—Flushing—Etoposide—uterine cancer	0.000288	0.00158	CcSEcCtD
Ezetimibe—ABCB1—uterus—uterine cancer	0.000288	0.00351	CbGeAlD
Ezetimibe—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000288	0.00158	CcSEcCtD
Ezetimibe—Photosensitivity—Epirubicin—uterine cancer	0.000287	0.00158	CcSEcCtD
Ezetimibe—Dizziness—Progesterone—uterine cancer	0.000285	0.00157	CcSEcCtD
Ezetimibe—Angiopathy—Etoposide—uterine cancer	0.000282	0.00155	CcSEcCtD
Ezetimibe—Immune system disorder—Etoposide—uterine cancer	0.00028	0.00154	CcSEcCtD
Ezetimibe—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00028	0.00154	CcSEcCtD
Ezetimibe—Hepatic failure—Epirubicin—uterine cancer	0.00028	0.00154	CcSEcCtD
Ezetimibe—Mediastinal disorder—Etoposide—uterine cancer	0.00028	0.00154	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000278	0.00153	CcSEcCtD
Ezetimibe—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000276	0.00152	CcSEcCtD
Ezetimibe—Alopecia—Etoposide—uterine cancer	0.000274	0.00151	CcSEcCtD
Ezetimibe—Vomiting—Progesterone—uterine cancer	0.000274	0.00151	CcSEcCtD
Ezetimibe—Rash—Progesterone—uterine cancer	0.000272	0.00149	CcSEcCtD
Ezetimibe—Dermatitis—Progesterone—uterine cancer	0.000272	0.00149	CcSEcCtD
Ezetimibe—Headache—Progesterone—uterine cancer	0.00027	0.00149	CcSEcCtD
Ezetimibe—Hot flush—Epirubicin—uterine cancer	0.000269	0.00148	CcSEcCtD
Ezetimibe—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000268	0.00147	CcSEcCtD
Ezetimibe—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000267	0.00147	CcSEcCtD
Ezetimibe—Menopausal symptoms—Epirubicin—uterine cancer	0.000267	0.00147	CcSEcCtD
Ezetimibe—Photosensitivity—Doxorubicin—uterine cancer	0.000265	0.00146	CcSEcCtD
Ezetimibe—Decreased appetite—Dactinomycin—uterine cancer	0.000265	0.00146	CcSEcCtD
Ezetimibe—Fatigue—Dactinomycin—uterine cancer	0.000263	0.00144	CcSEcCtD
Ezetimibe—Back pain—Etoposide—uterine cancer	0.000261	0.00144	CcSEcCtD
Ezetimibe—Pain—Dactinomycin—uterine cancer	0.000261	0.00143	CcSEcCtD
Ezetimibe—Muscle spasms—Etoposide—uterine cancer	0.00026	0.00143	CcSEcCtD
Ezetimibe—Hepatic failure—Doxorubicin—uterine cancer	0.000259	0.00142	CcSEcCtD
Ezetimibe—ABCB1—female reproductive system—uterine cancer	0.000259	0.00315	CbGeAlD
Ezetimibe—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000258	0.00142	CcSEcCtD
Ezetimibe—Nausea—Progesterone—uterine cancer	0.000256	0.00141	CcSEcCtD
Ezetimibe—Pain in extremity—Epirubicin—uterine cancer	0.000252	0.00138	CcSEcCtD
Ezetimibe—Feeling abnormal—Dactinomycin—uterine cancer	0.000251	0.00138	CcSEcCtD
Ezetimibe—Ill-defined disorder—Etoposide—uterine cancer	0.000251	0.00138	CcSEcCtD
Ezetimibe—Anaemia—Etoposide—uterine cancer	0.00025	0.00137	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000249	0.00137	CcSEcCtD
Ezetimibe—Hot flush—Doxorubicin—uterine cancer	0.000249	0.00137	CcSEcCtD
Ezetimibe—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000248	0.00137	CcSEcCtD
Ezetimibe—Menopausal symptoms—Doxorubicin—uterine cancer	0.000247	0.00136	CcSEcCtD
Ezetimibe—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000246	0.00135	CcSEcCtD
Ezetimibe—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000246	0.00135	CcSEcCtD
Ezetimibe—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000245	0.00135	CcSEcCtD
Ezetimibe—Malaise—Etoposide—uterine cancer	0.000244	0.00134	CcSEcCtD
Ezetimibe—Body temperature increased—Dactinomycin—uterine cancer	0.000241	0.00132	CcSEcCtD
Ezetimibe—Abdominal pain—Dactinomycin—uterine cancer	0.000241	0.00132	CcSEcCtD
Ezetimibe—Cough—Etoposide—uterine cancer	0.000236	0.0013	CcSEcCtD
Ezetimibe—ABCB1—female gonad—uterine cancer	0.000236	0.00287	CbGeAlD
Ezetimibe—ABCB1—vagina—uterine cancer	0.000234	0.00285	CbGeAlD
Ezetimibe—Hypertension—Etoposide—uterine cancer	0.000233	0.00128	CcSEcCtD
Ezetimibe—Pain in extremity—Doxorubicin—uterine cancer	0.000233	0.00128	CcSEcCtD
Ezetimibe—Liver function test abnormal—Epirubicin—uterine cancer	0.000232	0.00128	CcSEcCtD
Ezetimibe—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000232	0.00128	CcSEcCtD
Ezetimibe—Chest pain—Etoposide—uterine cancer	0.00023	0.00127	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000229	0.00126	CcSEcCtD
Ezetimibe—Discomfort—Etoposide—uterine cancer	0.000227	0.00125	CcSEcCtD
Ezetimibe—Breast disorder—Epirubicin—uterine cancer	0.000227	0.00125	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000227	0.00125	CcSEcCtD
Ezetimibe—Nasopharyngitis—Epirubicin—uterine cancer	0.000225	0.00124	CcSEcCtD
Ezetimibe—Hypersensitivity—Dactinomycin—uterine cancer	0.000225	0.00123	CcSEcCtD
Ezetimibe—Gastritis—Epirubicin—uterine cancer	0.000223	0.00122	CcSEcCtD
Ezetimibe—Confusional state—Etoposide—uterine cancer	0.000222	0.00122	CcSEcCtD
Ezetimibe—Muscular weakness—Epirubicin—uterine cancer	0.000222	0.00122	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000222	0.00122	CcSEcCtD
Ezetimibe—Anaphylactic shock—Etoposide—uterine cancer	0.000221	0.00121	CcSEcCtD
Ezetimibe—Infection—Etoposide—uterine cancer	0.000219	0.0012	CcSEcCtD
Ezetimibe—Asthenia—Dactinomycin—uterine cancer	0.000219	0.0012	CcSEcCtD
Ezetimibe—Influenza—Epirubicin—uterine cancer	0.000217	0.0012	CcSEcCtD
Ezetimibe—Thrombocytopenia—Etoposide—uterine cancer	0.000216	0.00119	CcSEcCtD
Ezetimibe—Eosinophilia—Epirubicin—uterine cancer	0.000215	0.00118	CcSEcCtD
Ezetimibe—Liver function test abnormal—Doxorubicin—uterine cancer	0.000215	0.00118	CcSEcCtD
Ezetimibe—Skin disorder—Etoposide—uterine cancer	0.000214	0.00118	CcSEcCtD
Ezetimibe—Pancreatitis—Epirubicin—uterine cancer	0.000213	0.00117	CcSEcCtD
Ezetimibe—Breast disorder—Doxorubicin—uterine cancer	0.00021	0.00116	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00021	0.00115	CcSEcCtD
Ezetimibe—Diarrhoea—Dactinomycin—uterine cancer	0.000209	0.00115	CcSEcCtD
Ezetimibe—Nasopharyngitis—Doxorubicin—uterine cancer	0.000208	0.00114	CcSEcCtD
Ezetimibe—Gastritis—Doxorubicin—uterine cancer	0.000206	0.00113	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000205	0.00113	CcSEcCtD
Ezetimibe—Muscular weakness—Doxorubicin—uterine cancer	0.000205	0.00113	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000202	0.00111	CcSEcCtD
Ezetimibe—Influenza—Doxorubicin—uterine cancer	0.000201	0.00111	CcSEcCtD
Ezetimibe—Eosinophilia—Doxorubicin—uterine cancer	0.000199	0.0011	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Epirubicin—uterine cancer	0.000198	0.00109	CcSEcCtD
Ezetimibe—Paraesthesia—Etoposide—uterine cancer	0.000198	0.00109	CcSEcCtD
Ezetimibe—Pancreatitis—Doxorubicin—uterine cancer	0.000197	0.00108	CcSEcCtD
Ezetimibe—Dyspnoea—Etoposide—uterine cancer	0.000197	0.00108	CcSEcCtD
Ezetimibe—Infestation NOS—Epirubicin—uterine cancer	0.000194	0.00107	CcSEcCtD
Ezetimibe—Infestation—Epirubicin—uterine cancer	0.000194	0.00107	CcSEcCtD
Ezetimibe—Vomiting—Dactinomycin—uterine cancer	0.000194	0.00107	CcSEcCtD
Ezetimibe—Rash—Dactinomycin—uterine cancer	0.000192	0.00106	CcSEcCtD
Ezetimibe—Decreased appetite—Etoposide—uterine cancer	0.000192	0.00105	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Etoposide—uterine cancer	0.00019	0.00105	CcSEcCtD
Ezetimibe—Fatigue—Etoposide—uterine cancer	0.00019	0.00105	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Epirubicin—uterine cancer	0.00019	0.00104	CcSEcCtD
Ezetimibe—Jaundice—Epirubicin—uterine cancer	0.000189	0.00104	CcSEcCtD
Ezetimibe—Pain—Etoposide—uterine cancer	0.000189	0.00104	CcSEcCtD
Ezetimibe—Constipation—Etoposide—uterine cancer	0.000189	0.00104	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000187	0.00103	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000184	0.00101	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Epirubicin—uterine cancer	0.000183	0.00101	CcSEcCtD
Ezetimibe—Sinusitis—Epirubicin—uterine cancer	0.000182	0.001	CcSEcCtD
Ezetimibe—Feeling abnormal—Etoposide—uterine cancer	0.000182	0.000999	CcSEcCtD
Ezetimibe—Nausea—Dactinomycin—uterine cancer	0.000181	0.000995	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Etoposide—uterine cancer	0.00018	0.000992	CcSEcCtD
Ezetimibe—Infestation NOS—Doxorubicin—uterine cancer	0.000179	0.000986	CcSEcCtD
Ezetimibe—Infestation—Doxorubicin—uterine cancer	0.000179	0.000986	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000176	0.000967	CcSEcCtD
Ezetimibe—Urticaria—Etoposide—uterine cancer	0.000175	0.000964	CcSEcCtD
Ezetimibe—Jaundice—Doxorubicin—uterine cancer	0.000175	0.000961	CcSEcCtD
Ezetimibe—Abdominal pain—Etoposide—uterine cancer	0.000174	0.000959	CcSEcCtD
Ezetimibe—Body temperature increased—Etoposide—uterine cancer	0.000174	0.000959	CcSEcCtD
Ezetimibe—Hepatitis—Epirubicin—uterine cancer	0.000174	0.000957	CcSEcCtD
Ezetimibe—Pharyngitis—Epirubicin—uterine cancer	0.000173	0.00095	CcSEcCtD
Ezetimibe—Oedema peripheral—Epirubicin—uterine cancer	0.000171	0.000943	CcSEcCtD
Ezetimibe—Connective tissue disorder—Epirubicin—uterine cancer	0.000171	0.00094	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00017	0.000933	CcSEcCtD
Ezetimibe—Sinusitis—Doxorubicin—uterine cancer	0.000168	0.000925	CcSEcCtD
Ezetimibe—Erythema multiforme—Epirubicin—uterine cancer	0.000165	0.000905	CcSEcCtD
Ezetimibe—Hypersensitivity—Etoposide—uterine cancer	0.000163	0.000894	CcSEcCtD
Ezetimibe—Flushing—Epirubicin—uterine cancer	0.000162	0.000888	CcSEcCtD
Ezetimibe—Hepatitis—Doxorubicin—uterine cancer	0.000161	0.000885	CcSEcCtD
Ezetimibe—Pharyngitis—Doxorubicin—uterine cancer	0.00016	0.000879	CcSEcCtD
Ezetimibe—Oedema peripheral—Doxorubicin—uterine cancer	0.000159	0.000872	CcSEcCtD
Ezetimibe—Asthenia—Etoposide—uterine cancer	0.000158	0.00087	CcSEcCtD
Ezetimibe—Connective tissue disorder—Doxorubicin—uterine cancer	0.000158	0.00087	CcSEcCtD
Ezetimibe—Angiopathy—Epirubicin—uterine cancer	0.000158	0.000868	CcSEcCtD
Ezetimibe—Immune system disorder—Epirubicin—uterine cancer	0.000157	0.000864	CcSEcCtD
Ezetimibe—Mediastinal disorder—Epirubicin—uterine cancer	0.000157	0.000862	CcSEcCtD
Ezetimibe—Pruritus—Etoposide—uterine cancer	0.000156	0.000858	CcSEcCtD
Ezetimibe—Alopecia—Epirubicin—uterine cancer	0.000154	0.000846	CcSEcCtD
Ezetimibe—Mental disorder—Epirubicin—uterine cancer	0.000152	0.000838	CcSEcCtD
Ezetimibe—Erythema multiforme—Doxorubicin—uterine cancer	0.000152	0.000837	CcSEcCtD
Ezetimibe—Erythema—Epirubicin—uterine cancer	0.000152	0.000833	CcSEcCtD
Ezetimibe—Malnutrition—Epirubicin—uterine cancer	0.000152	0.000833	CcSEcCtD
Ezetimibe—ABCB1—lymph node—uterine cancer	0.000151	0.00184	CbGeAlD
Ezetimibe—Diarrhoea—Etoposide—uterine cancer	0.000151	0.00083	CcSEcCtD
Ezetimibe—Flushing—Doxorubicin—uterine cancer	0.000149	0.000822	CcSEcCtD
Ezetimibe—Flatulence—Epirubicin—uterine cancer	0.000149	0.000821	CcSEcCtD
Ezetimibe—Back pain—Epirubicin—uterine cancer	0.000147	0.000806	CcSEcCtD
Ezetimibe—Angiopathy—Doxorubicin—uterine cancer	0.000146	0.000803	CcSEcCtD
Ezetimibe—Dizziness—Etoposide—uterine cancer	0.000146	0.000802	CcSEcCtD
Ezetimibe—Muscle spasms—Epirubicin—uterine cancer	0.000146	0.000801	CcSEcCtD
Ezetimibe—Immune system disorder—Doxorubicin—uterine cancer	0.000145	0.0008	CcSEcCtD
Ezetimibe—Mediastinal disorder—Doxorubicin—uterine cancer	0.000145	0.000798	CcSEcCtD
Ezetimibe—Alopecia—Doxorubicin—uterine cancer	0.000142	0.000782	CcSEcCtD
Ezetimibe—Mental disorder—Doxorubicin—uterine cancer	0.000141	0.000776	CcSEcCtD
Ezetimibe—Ill-defined disorder—Epirubicin—uterine cancer	0.000141	0.000773	CcSEcCtD
Ezetimibe—Vomiting—Etoposide—uterine cancer	0.00014	0.000771	CcSEcCtD
Ezetimibe—Erythema—Doxorubicin—uterine cancer	0.00014	0.000771	CcSEcCtD
Ezetimibe—Malnutrition—Doxorubicin—uterine cancer	0.00014	0.000771	CcSEcCtD
Ezetimibe—Anaemia—Epirubicin—uterine cancer	0.00014	0.00077	CcSEcCtD
Ezetimibe—Rash—Etoposide—uterine cancer	0.000139	0.000765	CcSEcCtD
Ezetimibe—Dermatitis—Etoposide—uterine cancer	0.000139	0.000764	CcSEcCtD
Ezetimibe—Headache—Etoposide—uterine cancer	0.000138	0.00076	CcSEcCtD
Ezetimibe—Flatulence—Doxorubicin—uterine cancer	0.000138	0.00076	CcSEcCtD
Ezetimibe—Malaise—Epirubicin—uterine cancer	0.000137	0.000751	CcSEcCtD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	0.000136	0.00162	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—STAR—uterine cancer	0.000136	0.00161	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKR1B1—uterine cancer	0.000136	0.00161	CbGpPWpGaD
Ezetimibe—Back pain—Doxorubicin—uterine cancer	0.000136	0.000746	CcSEcCtD
Ezetimibe—Muscle spasms—Doxorubicin—uterine cancer	0.000135	0.000741	CcSEcCtD
Ezetimibe—Palpitations—Epirubicin—uterine cancer	0.000134	0.000736	CcSEcCtD
Ezetimibe—Cough—Epirubicin—uterine cancer	0.000132	0.000727	CcSEcCtD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000132	0.00157	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000131	0.00156	CbGpPWpGaD
Ezetimibe—Nausea—Etoposide—uterine cancer	0.000131	0.00072	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—AKR1C3—uterine cancer	0.000131	0.00156	CbGpPWpGaD
Ezetimibe—Hypertension—Epirubicin—uterine cancer	0.000131	0.000719	CcSEcCtD
Ezetimibe—Ill-defined disorder—Doxorubicin—uterine cancer	0.00013	0.000715	CcSEcCtD
Ezetimibe—Anaemia—Doxorubicin—uterine cancer	0.00013	0.000712	CcSEcCtD
Ezetimibe—UGT1A1—Biological oxidations—CYP19A1—uterine cancer	0.000129	0.00154	CbGpPWpGaD
Ezetimibe—Myalgia—Epirubicin—uterine cancer	0.000129	0.000709	CcSEcCtD
Ezetimibe—Chest pain—Epirubicin—uterine cancer	0.000129	0.000709	CcSEcCtD
Ezetimibe—Arthralgia—Epirubicin—uterine cancer	0.000129	0.000709	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000128	0.000704	CcSEcCtD
Ezetimibe—UGT1A1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000127	0.00152	CbGpPWpGaD
Ezetimibe—Discomfort—Epirubicin—uterine cancer	0.000127	0.000701	CcSEcCtD
Ezetimibe—Malaise—Doxorubicin—uterine cancer	0.000126	0.000695	CcSEcCtD
Ezetimibe—Dry mouth—Epirubicin—uterine cancer	0.000126	0.000694	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000125	0.00149	CbGpPWpGaD
Ezetimibe—Confusional state—Epirubicin—uterine cancer	0.000125	0.000686	CcSEcCtD
Ezetimibe—Palpitations—Doxorubicin—uterine cancer	0.000124	0.000681	CcSEcCtD
Ezetimibe—Anaphylactic shock—Epirubicin—uterine cancer	0.000124	0.00068	CcSEcCtD
Ezetimibe—Infection—Epirubicin—uterine cancer	0.000123	0.000675	CcSEcCtD
Ezetimibe—Cough—Doxorubicin—uterine cancer	0.000122	0.000673	CcSEcCtD
Ezetimibe—Nervous system disorder—Epirubicin—uterine cancer	0.000121	0.000667	CcSEcCtD
Ezetimibe—Thrombocytopenia—Epirubicin—uterine cancer	0.000121	0.000666	CcSEcCtD
Ezetimibe—Hypertension—Doxorubicin—uterine cancer	0.000121	0.000665	CcSEcCtD
Ezetimibe—Skin disorder—Epirubicin—uterine cancer	0.00012	0.00066	CcSEcCtD
Ezetimibe—Chest pain—Doxorubicin—uterine cancer	0.000119	0.000656	CcSEcCtD
Ezetimibe—Myalgia—Doxorubicin—uterine cancer	0.000119	0.000656	CcSEcCtD
Ezetimibe—Arthralgia—Doxorubicin—uterine cancer	0.000119	0.000656	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000119	0.000652	CcSEcCtD
Ezetimibe—Discomfort—Doxorubicin—uterine cancer	0.000118	0.000648	CcSEcCtD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—uterine cancer	0.000117	0.00139	CbGpPWpGaD
Ezetimibe—Dry mouth—Doxorubicin—uterine cancer	0.000117	0.000642	CcSEcCtD
Ezetimibe—Confusional state—Doxorubicin—uterine cancer	0.000115	0.000634	CcSEcCtD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000115	0.00137	CbGpPWpGaD
Ezetimibe—Anaphylactic shock—Doxorubicin—uterine cancer	0.000114	0.000629	CcSEcCtD
Ezetimibe—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000114	0.00135	CbGpPWpGaD
Ezetimibe—Infection—Doxorubicin—uterine cancer	0.000114	0.000625	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000113	0.000619	CcSEcCtD
Ezetimibe—ANPEP—Metabolism of proteins—CCL2—uterine cancer	0.000112	0.00134	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Doxorubicin—uterine cancer	0.000112	0.000617	CcSEcCtD
Ezetimibe—Thrombocytopenia—Doxorubicin—uterine cancer	0.000112	0.000616	CcSEcCtD
Ezetimibe—Insomnia—Epirubicin—uterine cancer	0.000112	0.000615	CcSEcCtD
Ezetimibe—Skin disorder—Doxorubicin—uterine cancer	0.000111	0.000611	CcSEcCtD
Ezetimibe—Paraesthesia—Epirubicin—uterine cancer	0.000111	0.00061	CcSEcCtD
Ezetimibe—Dyspnoea—Epirubicin—uterine cancer	0.00011	0.000606	CcSEcCtD
Ezetimibe—Dyspepsia—Epirubicin—uterine cancer	0.000109	0.000598	CcSEcCtD
Ezetimibe—Decreased appetite—Epirubicin—uterine cancer	0.000108	0.000591	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000107	0.000587	CcSEcCtD
Ezetimibe—Fatigue—Epirubicin—uterine cancer	0.000107	0.000586	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—POLD1—uterine cancer	0.000106	0.00127	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CYP19A1—uterine cancer	0.000106	0.00126	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—STK11—uterine cancer	0.000106	0.00126	CbGpPWpGaD
Ezetimibe—Constipation—Epirubicin—uterine cancer	0.000106	0.000581	CcSEcCtD
Ezetimibe—Pain—Epirubicin—uterine cancer	0.000106	0.000581	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—MTHFR—uterine cancer	0.000105	0.00125	CbGpPWpGaD
Ezetimibe—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000105	0.00125	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000105	0.00124	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	0.000104	0.00124	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000104	0.000573	CcSEcCtD
Ezetimibe—Insomnia—Doxorubicin—uterine cancer	0.000103	0.000569	CcSEcCtD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000103	0.00123	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000103	0.00123	CbGpPWpGaD
Ezetimibe—Paraesthesia—Doxorubicin—uterine cancer	0.000103	0.000565	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—CYP19A1—uterine cancer	0.000102	0.00121	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—STK11—uterine cancer	0.000102	0.00121	CbGpPWpGaD
Ezetimibe—Dyspnoea—Doxorubicin—uterine cancer	0.000102	0.000561	CcSEcCtD
Ezetimibe—Feeling abnormal—Epirubicin—uterine cancer	0.000102	0.00056	CcSEcCtD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000102	0.00121	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Epirubicin—uterine cancer	0.000101	0.000556	CcSEcCtD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000101	0.0012	CbGpPWpGaD
Ezetimibe—Dyspepsia—Doxorubicin—uterine cancer	0.000101	0.000554	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—NDUFB11—uterine cancer	0.000101	0.0012	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SRD5A2—uterine cancer	0.000101	0.0012	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKR1C1—uterine cancer	9.96e-05	0.00118	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.95e-05	0.00118	CbGpPWpGaD
Ezetimibe—Decreased appetite—Doxorubicin—uterine cancer	9.95e-05	0.000547	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.88e-05	0.000543	CcSEcCtD
Ezetimibe—Fatigue—Doxorubicin—uterine cancer	9.87e-05	0.000542	CcSEcCtD
Ezetimibe—Urticaria—Epirubicin—uterine cancer	9.82e-05	0.00054	CcSEcCtD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ABCC9—uterine cancer	9.82e-05	0.00117	CbGpPWpGaD
Ezetimibe—Constipation—Doxorubicin—uterine cancer	9.79e-05	0.000538	CcSEcCtD
Ezetimibe—Pain—Doxorubicin—uterine cancer	9.79e-05	0.000538	CcSEcCtD
Ezetimibe—Body temperature increased—Epirubicin—uterine cancer	9.78e-05	0.000537	CcSEcCtD
Ezetimibe—Abdominal pain—Epirubicin—uterine cancer	9.78e-05	0.000537	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.58e-05	0.00114	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.49e-05	0.00113	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Doxorubicin—uterine cancer	9.43e-05	0.000518	CcSEcCtD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—EP300—uterine cancer	9.41e-05	0.00112	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Doxorubicin—uterine cancer	9.36e-05	0.000514	CcSEcCtD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	9.35e-05	0.00111	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.26e-05	0.0011	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.14e-05	0.00109	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Epirubicin—uterine cancer	9.11e-05	0.000501	CcSEcCtD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	9.1e-05	0.00108	CbGpPWpGaD
Ezetimibe—Urticaria—Doxorubicin—uterine cancer	9.09e-05	0.0005	CcSEcCtD
Ezetimibe—Body temperature increased—Doxorubicin—uterine cancer	9.05e-05	0.000497	CcSEcCtD
Ezetimibe—Abdominal pain—Doxorubicin—uterine cancer	9.05e-05	0.000497	CcSEcCtD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	8.91e-05	0.00106	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—CXCL8—uterine cancer	8.89e-05	0.00106	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—RRM2—uterine cancer	8.88e-05	0.00106	CbGpPWpGaD
Ezetimibe—Asthenia—Epirubicin—uterine cancer	8.87e-05	0.000488	CcSEcCtD
Ezetimibe—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	8.8e-05	0.00105	CbGpPWpGaD
Ezetimibe—Pruritus—Epirubicin—uterine cancer	8.75e-05	0.000481	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—DCN—uterine cancer	8.62e-05	0.00103	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NDUFB11—uterine cancer	8.55e-05	0.00102	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SRD5A2—uterine cancer	8.55e-05	0.00102	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SRD5A2—uterine cancer	8.55e-05	0.00102	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NDUFB11—uterine cancer	8.55e-05	0.00102	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	8.48e-05	0.00101	CbGpPWpGaD
Ezetimibe—Diarrhoea—Epirubicin—uterine cancer	8.46e-05	0.000465	CcSEcCtD
Ezetimibe—Hypersensitivity—Doxorubicin—uterine cancer	8.43e-05	0.000463	CcSEcCtD
Ezetimibe—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	8.37e-05	0.000996	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.3e-05	0.000988	CbGpPWpGaD
Ezetimibe—Asthenia—Doxorubicin—uterine cancer	8.21e-05	0.000451	CcSEcCtD
Ezetimibe—ANPEP—Metabolism of proteins—CTNNB1—uterine cancer	8.2e-05	0.000976	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	8.18e-05	0.000974	CbGpPWpGaD
Ezetimibe—Dizziness—Epirubicin—uterine cancer	8.18e-05	0.00045	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—CYP11A1—uterine cancer	8.12e-05	0.000966	CbGpPWpGaD
Ezetimibe—Pruritus—Doxorubicin—uterine cancer	8.1e-05	0.000445	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—MTHFR—uterine cancer	7.97e-05	0.000948	CbGpPWpGaD
Ezetimibe—Vomiting—Epirubicin—uterine cancer	7.86e-05	0.000432	CcSEcCtD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.84e-05	0.000933	CbGpPWpGaD
Ezetimibe—Diarrhoea—Doxorubicin—uterine cancer	7.83e-05	0.00043	CcSEcCtD
Ezetimibe—Rash—Epirubicin—uterine cancer	7.8e-05	0.000429	CcSEcCtD
Ezetimibe—Dermatitis—Epirubicin—uterine cancer	7.79e-05	0.000428	CcSEcCtD
Ezetimibe—Headache—Epirubicin—uterine cancer	7.75e-05	0.000426	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—MTHFR—uterine cancer	7.67e-05	0.000913	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKR1C3—uterine cancer	7.67e-05	0.000912	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.58e-05	0.000902	CbGpPWpGaD
Ezetimibe—Dizziness—Doxorubicin—uterine cancer	7.57e-05	0.000416	CcSEcCtD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	7.35e-05	0.000875	CbGpPWpGaD
Ezetimibe—Nausea—Epirubicin—uterine cancer	7.35e-05	0.000404	CcSEcCtD
Ezetimibe—Vomiting—Doxorubicin—uterine cancer	7.28e-05	0.0004	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—STAR—uterine cancer	7.27e-05	0.000865	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKR1B1—uterine cancer	7.27e-05	0.000865	CbGpPWpGaD
Ezetimibe—Rash—Doxorubicin—uterine cancer	7.21e-05	0.000397	CcSEcCtD
Ezetimibe—Dermatitis—Doxorubicin—uterine cancer	7.21e-05	0.000396	CcSEcCtD
Ezetimibe—Headache—Doxorubicin—uterine cancer	7.17e-05	0.000394	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.02e-05	0.000835	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SRD5A2—uterine cancer	6.94e-05	0.000826	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NDUFB11—uterine cancer	6.94e-05	0.000826	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.88e-05	0.000818	CbGpPWpGaD
Ezetimibe—Nausea—Doxorubicin—uterine cancer	6.8e-05	0.000374	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.76e-05	0.000804	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	6.48e-05	0.000771	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SRD5A2—uterine cancer	6.36e-05	0.000757	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NDUFB11—uterine cancer	6.36e-05	0.000757	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.18e-05	0.000736	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKR1B1—uterine cancer	6.18e-05	0.000735	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—STAR—uterine cancer	6.18e-05	0.000735	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—STAR—uterine cancer	6.18e-05	0.000735	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKR1B1—uterine cancer	6.18e-05	0.000735	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.11e-05	0.000727	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.01e-05	0.000715	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	6e-05	0.000714	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—STK11—uterine cancer	5.97e-05	0.000711	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CYP19A1—uterine cancer	5.97e-05	0.000711	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SRD5A2—uterine cancer	5.89e-05	0.000701	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NDUFB11—uterine cancer	5.89e-05	0.000701	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTEN—uterine cancer	5.85e-05	0.000696	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.84e-05	0.000695	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—POLD1—uterine cancer	5.7e-05	0.000678	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	5.69e-05	0.000676	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—EP300—uterine cancer	5.58e-05	0.000664	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	5.45e-05	0.000649	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKR1C1—uterine cancer	5.33e-05	0.000635	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.27e-05	0.000627	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CXCL8—uterine cancer	5.14e-05	0.000611	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	5.09e-05	0.000605	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKR1B1—uterine cancer	5.02e-05	0.000597	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—STAR—uterine cancer	5.02e-05	0.000597	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	4.97e-05	0.000591	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	4.92e-05	0.000585	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	4.9e-05	0.000583	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.89e-05	0.000582	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—POLD1—uterine cancer	4.85e-05	0.000577	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—POLD1—uterine cancer	4.85e-05	0.000577	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	4.82e-05	0.000573	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—RRM2—uterine cancer	4.75e-05	0.000566	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.62e-05	0.00055	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—DCN—uterine cancer	4.62e-05	0.000549	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—STAR—uterine cancer	4.6e-05	0.000547	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKR1B1—uterine cancer	4.6e-05	0.000547	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.55e-05	0.000541	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKR1C1—uterine cancer	4.54e-05	0.00054	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKR1C1—uterine cancer	4.54e-05	0.00054	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—MTHFR—uterine cancer	4.49e-05	0.000534	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTEN—uterine cancer	4.43e-05	0.000527	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP11A1—uterine cancer	4.35e-05	0.000517	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTEN—uterine cancer	4.27e-05	0.000508	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—STAR—uterine cancer	4.26e-05	0.000507	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKR1B1—uterine cancer	4.26e-05	0.000507	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—EP300—uterine cancer	4.23e-05	0.000503	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—VEGFA—uterine cancer	4.17e-05	0.000496	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PIK3CA—uterine cancer	4.13e-05	0.000491	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKR1C3—uterine cancer	4.11e-05	0.000489	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—EP300—uterine cancer	4.07e-05	0.000484	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—RRM2—uterine cancer	4.04e-05	0.000481	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—RRM2—uterine cancer	4.04e-05	0.000481	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—POLD1—uterine cancer	3.94e-05	0.000469	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—DCN—uterine cancer	3.92e-05	0.000467	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—DCN—uterine cancer	3.92e-05	0.000467	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP11A1—uterine cancer	3.7e-05	0.00044	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP11A1—uterine cancer	3.7e-05	0.00044	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKR1C1—uterine cancer	3.69e-05	0.000438	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.65e-05	0.000435	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3.64e-05	0.000433	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—POLD1—uterine cancer	3.61e-05	0.00043	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.6e-05	0.000429	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKR1C3—uterine cancer	3.49e-05	0.000415	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKR1C3—uterine cancer	3.49e-05	0.000415	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKR1C1—uterine cancer	3.38e-05	0.000402	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—AKT1—uterine cancer	3.37e-05	0.000401	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—POLD1—uterine cancer	3.34e-05	0.000398	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—RRM2—uterine cancer	3.28e-05	0.000391	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—STK11—uterine cancer	3.2e-05	0.000381	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP19A1—uterine cancer	3.2e-05	0.000381	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DCN—uterine cancer	3.19e-05	0.000379	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SRD5A2—uterine cancer	3.19e-05	0.000379	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NDUFB11—uterine cancer	3.19e-05	0.000379	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PIK3CA—uterine cancer	3.13e-05	0.000372	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKR1C1—uterine cancer	3.13e-05	0.000372	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	3.07e-05	0.000366	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CA—uterine cancer	3.01e-05	0.000358	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—RRM2—uterine cancer	3.01e-05	0.000358	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP11A1—uterine cancer	3e-05	0.000357	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DCN—uterine cancer	2.92e-05	0.000348	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKR1C3—uterine cancer	2.84e-05	0.000338	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—RRM2—uterine cancer	2.79e-05	0.000332	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP11A1—uterine cancer	2.75e-05	0.000328	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP19A1—uterine cancer	2.72e-05	0.000324	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—STK11—uterine cancer	2.72e-05	0.000324	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—STK11—uterine cancer	2.72e-05	0.000324	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP19A1—uterine cancer	2.72e-05	0.000324	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DCN—uterine cancer	2.71e-05	0.000322	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.67e-05	0.000318	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.6e-05	0.000309	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AKT1—uterine cancer	2.55e-05	0.000304	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.55e-05	0.000304	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP11A1—uterine cancer	2.55e-05	0.000303	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTEN—uterine cancer	2.5e-05	0.000297	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.48e-05	0.000295	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AKT1—uterine cancer	2.46e-05	0.000293	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.43e-05	0.00029	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKR1C3—uterine cancer	2.41e-05	0.000286	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MTHFR—uterine cancer	2.4e-05	0.000286	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—EP300—uterine cancer	2.38e-05	0.000283	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.34e-05	0.000278	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKR1B1—uterine cancer	2.3e-05	0.000274	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—STAR—uterine cancer	2.3e-05	0.000274	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.28e-05	0.000271	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—STK11—uterine cancer	2.21e-05	0.000263	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP19A1—uterine cancer	2.21e-05	0.000263	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.17e-05	0.000259	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.06e-05	0.000245	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MTHFR—uterine cancer	2.04e-05	0.000243	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MTHFR—uterine cancer	2.04e-05	0.000243	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP19A1—uterine cancer	2.03e-05	0.000241	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—STK11—uterine cancer	2.03e-05	0.000241	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.96e-05	0.000234	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.96e-05	0.000234	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.9e-05	0.000226	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—STK11—uterine cancer	1.88e-05	0.000223	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP19A1—uterine cancer	1.88e-05	0.000223	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.81e-05	0.000216	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—POLD1—uterine cancer	1.81e-05	0.000215	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.8e-05	0.000214	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CA—uterine cancer	1.76e-05	0.00021	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.75e-05	0.000208	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKR1C1—uterine cancer	1.69e-05	0.000201	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MTHFR—uterine cancer	1.66e-05	0.000198	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.61e-05	0.000191	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.56e-05	0.000185	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.52e-05	0.000181	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—RRM2—uterine cancer	1.51e-05	0.000179	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DCN—uterine cancer	1.46e-05	0.000174	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—uterine cancer	1.44e-05	0.000171	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.42e-05	0.000169	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—STAR—uterine cancer	1.42e-05	0.000169	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MTHFR—uterine cancer	1.41e-05	0.000168	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.000164	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.34e-05	0.00016	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTEN—uterine cancer	1.34e-05	0.000159	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.31e-05	0.000156	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000155	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—EP300—uterine cancer	1.28e-05	0.000152	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTEN—uterine cancer	1.14e-05	0.000135	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTEN—uterine cancer	1.14e-05	0.000135	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—POLD1—uterine cancer	1.11e-05	0.000132	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—EP300—uterine cancer	1.08e-05	0.000129	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—EP300—uterine cancer	1.08e-05	0.000129	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.04e-05	0.000124	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP19A1—uterine cancer	1.01e-05	0.000121	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—STK11—uterine cancer	1.01e-05	0.000121	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CA—uterine cancer	9.43e-06	0.000112	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—RRM2—uterine cancer	9.28e-06	0.00011	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTEN—uterine cancer	9.24e-06	0.00011	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DCN—uterine cancer	9.01e-06	0.000107	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—EP300—uterine cancer	8.81e-06	0.000105	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP11A1—uterine cancer	8.49e-06	0.000101	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTEN—uterine cancer	8.47e-06	0.000101	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—EP300—uterine cancer	8.07e-06	9.61e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CA—uterine cancer	8.02e-06	9.54e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CA—uterine cancer	8.02e-06	9.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKR1C3—uterine cancer	8.02e-06	9.54e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTEN—uterine cancer	7.84e-06	9.33e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—uterine cancer	7.71e-06	9.17e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTHFR—uterine cancer	7.62e-06	9.07e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—EP300—uterine cancer	7.48e-06	8.9e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—uterine cancer	6.55e-06	7.8e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—uterine cancer	6.55e-06	7.8e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CA—uterine cancer	6.52e-06	7.76e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.25e-06	7.43e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—STK11—uterine cancer	6.25e-06	7.43e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CA—uterine cancer	5.97e-06	7.11e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CA—uterine cancer	5.53e-06	6.58e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—uterine cancer	5.33e-06	6.34e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—uterine cancer	4.88e-06	5.81e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTHFR—uterine cancer	4.69e-06	5.59e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—uterine cancer	4.52e-06	5.38e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTEN—uterine cancer	4.24e-06	5.04e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—EP300—uterine cancer	4.04e-06	4.81e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CA—uterine cancer	2.99e-06	3.56e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTEN—uterine cancer	2.61e-06	3.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—EP300—uterine cancer	2.49e-06	2.96e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—uterine cancer	2.44e-06	2.91e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.84e-06	2.19e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—uterine cancer	1.51e-06	1.79e-05	CbGpPWpGaD
